Centerspace
CSRNYSEReal Estate● Active
$58.33
$-0.93(-1.57%)
Market Cap$980124823
P/E Ratio—
52W High$69.61
52W Low$52.76
Centerspace（CSR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSR · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.35B | $0.26B | $0.26B | $0.26B | $0.20B |
| Cost of Revenue | $0.34B | $0.11B | $0.12B | $0.12B | $0.09B |
| Gross Profit | $0.01B | $0.15B | $0.15B | $0.14B | $0.11B |
| Gross Margin %(computed) | 3.05% | 56.94% | 55.93% | 53.83% | 55.08% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| Total Operating Expenses | ($0.09B) | $0.13B | $0.06B | $0.12B | $0.08B |
| Operating Income | $0.10B | $0.02B | $0.08B | $0.01B | $0.03B |
| Operating Margin %(computed) | 29.19% | 7.85% | 32.32% | 5.40% | 14.82% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.04B | $0.04B | $0.04B | $0.03B | $0.03B |
| Income Before Tax | $0.02B | ($0.01B) | $0.05B | ($0.02B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.02B | ($0.01B) | $0.04B | ($0.01B) | $0.00B |
| Net Margin %(computed) | 4.98% | -4.10% | 16.06% | -5.25% | 0.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.02 | $-1.27 | $2.65 | $-0.99 | $-2.27 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.01B | 0.02B | 0.01B |
| EBITDA | $0.18B | $0.13B | $0.19B | $0.12B | $0.12B |
| EBITDA Margin %(computed) | 51.16% | 50.09% | 72.26% | 47.26% | 60.98% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Centerspace
关于Centerspace（CSR）损益表
Centerspace（CSR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CSR实现营收$0.35B，毛利润$0.01B（毛利率3.05%），净利润$0.02B（净利率4.98%）。
常见问题
CSR · 4 问Centerspace（CSR）2025财年营收为$0.35B，同比up35.3%。
CSR revenueCSR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08